Tumor specific killer cell preparation and preparation method thereof
A tumor-specific, cell-killing technology, which is applied in the field of tumor-specific cell-killing preparations and its preparation, can solve the problems of low clinical effective rate and low tumor killing rate, and achieve improved killing efficiency, excellent curative effect, and high recovery rate. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0047] 1. Precautions before blood collection:
[0048] Because radiotherapy and chemotherapy will greatly affect the content and function of initial T cells in peripheral blood and bone marrow, it is more appropriate to collect peripheral blood mononuclear cells after radical surgery or one month after radiotherapy and chemotherapy in patients with advanced tumors. When the number of peripheral blood leukocytes is low, recombinant human granulocyte-macrophage-colony-stimulating factor for injection (rhGM-CSF) can be injected subcutaneously for bone marrow mobilization. For tumor patients with multiple bone marrow metastases or low bone marrow hematopoietic function, the content and function of initial T cells in peripheral blood are poor, so it is not suitable to collect peripheral blood mononuclear cells.
[0049] 2. Collection of peripheral blood mononuclear cells:
[0050] Use the COBESPECTRA cell component separator, set the parameters and program according to the instru...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com